Monitored vitamin D therapy safe for patients with high blood calcium levels

June 26, 2012

Patients with a gland disorder that causes excessive calcium in their blood who also have vitamin D deficiency can safely receive vitamin D treatment without it raising their calcium levels, a new study has determined. The results with one-year follow-up will be presented Tuesday at The Endocrine Society's 94th Annual Meeting in Houston.

Doctors often fear that raising vitamin D levels will further raise calcium in patients with primary hyperparathyroidism—in which glands in the neck produce too much of the parathyroid hormone, which controls . Yet without enough vitamin D, people are at increased risk of osteoporosis and broken bones. Vitamin D helps the body absorb calcium and is vital for bone health.

"These patients need close monitoring every three to four months during vitamin D replacement therapy," said Dima Abdelmannan, MD, an assistant professor at Case Western Reserve University in Cleveland and an endocrinologist at Cleveland Veterans Affairs (VA) Medical Center.

Abdelmannan, who presented the research findings, said doctors should measure blood levels of calcium and parathyroid hormone along with vitamin D levels throughout treatment.

"Measuring vitamin D levels alone may not be helpful in the management of in patients with primary hyperparathyroidism," she said. "The commercially available blood test for vitamin D level—the 25-hydroxyvitamin D—has limitations."

For this study, Abdelmannan and colleagues reviewed the medical records of 32 patients at the VA Medical Center who had both primary hyperparathyroidism and vitamin D deficiency. All 10 women and 22 men had hypercalcemia, or high calcium in the blood, defined as a level greater than 10.1 milligrams per deciliter (mg/dL). They also had vitamin D levels below the cutoff for normal of 30 nanograms per deciliter (ng/dL) on the 25-hydroxyvitamin D test for vitamin D.

Patients received either vitamin D2 (ergocalciferol) or vitamin D3 (cholecalciferol) at an average daily dose of 3,630 International Units, or IU. Most patients had their parathyroid hormone, calcium and vitamin D levels checked every three months for a year after vitamin D treatment.

Vitamin D levels returned to normal with treatment and remained normal at all intervals. Abdelmannan said the average calcium blood level "remained virtually unchanged" from the pretreatment level of 10.7 mg/dL. The calcium level was 10.8 mg/dL at three months after treatment, 10.6 at six months and 10.7 at 12 months, the authors reported. Despite calcium levels not rising, levels decreased, from an average of 124 picograms per deciliter (pg/dL) before treatment to 103 pg/dL one year after treatment.

Hyperparathyroidism develops in approximately 100,000 Americans every year and affects twice as many women as men, according to the National Institutes of Health. The risk increases with age. Although the disorder usually has no symptoms, if calcium levels are very high, it can cause bone aches, tiredness and kidney stones, Abdelmannan said.

The Endocrine Society, in its 2011 guideline on treating vitamin D deficiency, suggests that with primary hyperparathyroidism and vitamin D deficiency receive treatment as needed and that serum () calcium levels should be monitored.

Explore further: Vitamin D deficiency high among trauma patients

Related Stories

Vitamin D deficiency high among trauma patients

February 7, 2012
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that 77 percent of trauma patients had deficient or insufficient levels of vitamin D.

Vitamin D: A double-edged sword in the fight against osteoporosis?

April 23, 2012
Vitamin D is renowned for its role in creating strong bones and is a key regulator of serum calcium levels. Calcium is primarily obtained through diet and absorbed through the intestine and into the blood stream. In addition ...

Investigational hormone replacement promising treatment for rare disorder

June 25, 2012
An investigational parathyroid hormone replacement effectively treated a rare disorder characterized by low calcium and high phosphate levels in the blood, a new study finds. The results will be presented at The Endocrine ...

Vitamin D with calcium shown to reduce mortality in elderly

June 15, 2012
A study recently published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that vitamin D—when taken with calcium—can reduce the rate of mortality in seniors, therefore ...

Recommended for you

Amber-tinted glasses may provide relief for insomnia

December 15, 2017
How do you unwind before bedtime? If your answer involves Facebook and Netflix, you are actively reducing your chance of a good night's sleep. And you are not alone: 90 percent of Americans use light-emitting electronic devices, ...

Warning labels can help reduce soda consumption and obesity, new study suggests

December 15, 2017
Labels that warn people about the risks of drinking soda and other sugar-sweetened beverages can lower obesity and overweight prevalence, suggests a new Johns Hopkins Bloomberg School of Public Health study.

Office work can be a pain in the neck

December 15, 2017
Neck pain is a common condition among office workers, but regular workplace exercises can prevent and reduce it, a University of Queensland study has found.

Regular takeaways linked to kids' heart disease and diabetes risk factors

December 14, 2017
Kids who regularly eat take-away meals may be boosting their risk factors for heart disease and diabetes, suggests research published online in the Archives of Disease in Childhood.

Simulation model finds Cure Violence program and targeted policing curb urban violence

December 14, 2017
When communities and police work together to deter urban violence, they can achieve better outcomes with fewer resources than when each works in isolation, a simulation model created by researchers at the UC Davis Violence ...

One in five patients report discrimination in health care

December 14, 2017
Almost one in five older patients with a chronic disease reported experiencing health care discrimination of one type or another in a large national survey that asked about their daily experiences of discrimination between ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.